Clinical Trial Update: Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pemetrexed in advanced non-small-cell lung cancer comparing progression at progression versus maintenance therapy after induct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Carcinoma, Non-small-cell Lung | Phase 3 | Status: TERMINATED